The Global High End Cellomics Market Growth Accelerated By Increased Adoption In Drug Research And Discovery
High End Cellomics Market |
High-end cellomics technology plays a vital role in drug discovery and research by enabling applications like high-content screening, cell imaging and analysis, and flow cytometry. It assists in the identification of gene functions, cellular protein analysis, and cell population phenotyping through imaging and characterization of cells.
The global High-End
Cellomics Market is estimated to be valued at US$ 3.9 Bn in 2023 and is
expected to exhibit a CAGR of 6.2% over
the forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The increased adoption of high end cellomics technology in drug research and
discovery has been a major factor driving the growth of the high end cellomics
market. Technological advancements have enabled researchers to analyze cellular
composition, structure and function at an advanced level. High content
screening systems coupled with advanced analytical software provide
comprehensive profiling of cell lines to identify and validate new drug
targets. Key players are investing heavily in development of more sophisticated
cellomics platforms to facilitate a
ccuracy and efficiency of drug discovery process. This has significantly accelerated the adoption of cellomics technology in pharmaceutical and biotech sector over the recent years.
ccuracy and efficiency of drug discovery process. This has significantly accelerated the adoption of cellomics technology in pharmaceutical and biotech sector over the recent years.
Segment Analysis
The global high end cellomics market can be segmented based on application into
drug discovery, stem cell research, cell biology research, and others. Among
these, drug discovery dominates the market and is estimated to have a market
share of over 30% in 2023. The dominance is attributed to the increasing
adoption of high-content screening techniques in drug discovery for
protein-protein interaction and compound screening studies.
Key Takeaways
The global High
End Cellomics Market Share is expected to witness high growth during the
forecast period of 2023 to 2030. Fueled by rising public-private investments
directed towards biological and biomedical research, the market demand for
high-content screening instruments and services is estimated to spike.
Regional analysis
Regionally, North America is expected to dominate the high end cellomics market
during the forecast period. The region accounts for over 35% revenue share in
the global market in 2023. Extensive ongoing R&D activities and
availability of state-of-the-art research infrastructure primarily support the
growth of the regional market. Further, Asia Pacific is projected to witness
the fastest growth during the forecast period. This can be attributed to the
increased focus of key players on expanding their presence, coupled with rising
government support for pharmaceutical and biotechnology industry.
Key players
Key players operating in the high end cellomics market are Vinci, Bouygues,
Grupo ACS, Hochtief, Balfour Beatty, Laing O’Rourke, Bechtel, Kiewit, HOCHTIEF,
and Skanska. Vinci and Bouygues collectively account for nearly 15% of the
global market revenue. Their leadership is backed by strong portfolio of
analytical instruments and continued focus on new product development.
Get More Insights On This Topic: https://www.ukwebwire.com/the-high-end-cellomics-market-driven-by-advancements-in-
ai-applications/
Comments
Post a Comment